Skip to main navigation Skip to search Skip to main content

EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care

  • S. Lau
  • , V. Backer
  • , G. K. Scadding
  • , P. J. Barnes
  • , M. Bernal Sprekelsen
  • , X. Bertels
  • , M. Blaiss
  • , E. Borzova
  • , M. C. Brüggen
  • , L. O. Cardell
  • , D. M. Conti
  • , M. Cornet
  • , E. De Corso
  • , R. Djukanovic
  • , W. J. Fokkens
  • , A. T. Fox
  • , M. Gaga
  • , P. Gevaert
  • , P. Gibson
  • , C. L. Gray
  • L. G. Heaney, E. Heffler, H. J. Hoffmann, C. Hopkins, D. Jackson, M. Jesenak, P. Johansen, E. Khaleva, S. Lee, M. J. Mäkelä, E. Melén, J. Mullol, A. Nieto, I. Pavord, A. Peters, D. Price, S. Quirce, D. Ryan, S. Schneider, B. Senior, C. M.E. Shire, P. Smith, T. Teeling, J. C. Virchow, V. Lund, U. Wahn, P. W. Hellings

Research output: Contribution to journalArticlepeer-review

Abstract

EUFOREA, the European Forum for Research and Education in Allergy and Airways diseases, is an international non-for-profit organisation of physicians, patients, and other stakeholders committed to the improvement of outcomes for patients suffering from chronic inflammatory respiratory conditions through collaborative research, education, and targeted advocacy. In February 2025, EUFOREA hosted its biennial summit in Brussels, convening expert panels, its Patient Advisory Board, and a range of leadership representatives. This event was pivotal in establishing the research, educational, and advocacy priorities for the subsequent 2-year period, coinciding with the organisation's 10th anniversary in April 2025. Building on its core competencies, EUFOREA advances evidence-based clinical tools and educational initiatives designed to narrow the gap between emerging science and routine care. In alignment with the objective of enhancing global healthcare standards, the specialists' panels of chronic rhinosinusitis and European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), allergic rhinitis, asthma, allergen immunotherapy, and paediatrics have devised and detailed a comprehensive range of initiatives that address significant unmet needs within the domains of allergy and respiratory care. This document presents a summary of EUFOREA's future objectives, aspirations, and strategy, providing a clear direction for the coming years. It serves as a valuable resource for individuals and organisations involved in both the allergy and the respiratory sectors, offering a comprehensive overview of the association's plans and initiatives.

Original languageEnglish (US)
Article number1745834
JournalFrontiers in Allergy
Volume7
DOIs
StatePublished - 2026
Externally publishedYes

Bibliographical note

Publisher Copyright:
2026 Lau, Backer, Scadding, Barnes, Bernal Sprekelsen, Bertels, Blaiss, Borzova, Brüggen, Cardell, Conti, Cornet, De Corso, Djukanovic, Fokkens, Fox, Gaga, Gevaert, Gibson, Gray, Heaney, Heffler, Hoffmann, Hopkins, Jackson, Jesenak, Johansen, Khaleva, Lee, Mäkelä, Melén, Mullol, Nieto, Pavord, Peters, Price, Quirce, Ryan, Schneider, Senior, Shire, Smith, Teeling, Virchow, Lund, Wahn and Hellings.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COPD
  • EUFOREA
  • allergen immunotherapy
  • asthma
  • paediatric allergy
  • rhinitis
  • rhinosinusitis
  • summit

Fingerprint

Dive into the research topics of 'EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care'. Together they form a unique fingerprint.

Cite this